Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioannis Gioulbasanis

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
EMBO Molecular Medicine|April 13, 2012
Selecting for predisposition to cancer cachexiaIoannis Gioulbasanis, Panagiotis J Vlachostergios, Christos N Papandreou
JPEN. Journal of Parenteral and Enteral Nutrition|April 24, 2019
Cancer-Associated Malnutrition and CT-Defined Sarcopenia and Myosteatosis Are Endemic in Overweight and Obese PatientsLisa Martin, Ioannis Gioulbasanis, Pierre Senesse, et al.
Nutrition and Cancer|August 24, 2016
Detailed Dietary Assessment in Patients with Inoperable Tumors: Potential Deficits for Nutrition Care PlansNikoletta Vidra, Meropi D Kontogianni, Evaggelia Schina, et al.
The American Journal of Clinical Nutrition|February 19, 2010
Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysisVickie E Baracos, Tony Reiman, Marina Mourtzakis, et al.
European Journal of Pharmacology|August 4, 2011
Beyond anorexia -cachexia. Nutrition and modulation of cancer patients' metabolism: supplementary, complementary or alternative anti-neoplastic therapy?Alessandro Laviano, Marilia Seelaender, Karla Sanchez-Lara, et al.
Life (Basel, Switzerland)|June 24, 2022
Cancer Cachexia and Antitumor Immunity: Common Mediators and Potential Targets for New TherapiesKonstantinos Rounis, Dimitrios Makrakis, Ioannis Gioulbasanis, et al.
Nutrition and Cancer|January 23, 2023
Objective Measurements of Physical Function to Predict Survival in Patients with Metastatic CancerIoannis Migdanis, Ioannis Gioulbasanis, Athanasios Migdanis, et al.
Journal of Negative Results in Biomedicine|January 7, 2012
Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancerPanagiotis J Vlachostergios, Foteini Karasavvidou, Grigorios Kakkas, et al.
Anticancer Research|November 27, 2008
Gefitinib in combination with gemcitabine and vinorelbine in patients with metastatic breast cancer pre-treated with taxane and anthracycline chemotherapy: a phase I/II trialIoannis Gioulbasanis, Zacharenia Saridaki, Antonia Kalykaki, et al.
Cancer Chemotherapy and Pharmacology|September 11, 2010
Α multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancerNikolaos Xenidis, Nikolaos Vardakis, Ioannis Varthalitis, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
EMBO Molecular Medicine|April 13, 2012
Selecting for predisposition to cancer cachexiaIoannis Gioulbasanis, Panagiotis J Vlachostergios, Christos N Papandreou
JPEN. Journal of Parenteral and Enteral Nutrition|April 24, 2019
Cancer-Associated Malnutrition and CT-Defined Sarcopenia and Myosteatosis Are Endemic in Overweight and Obese PatientsLisa Martin, Ioannis Gioulbasanis, Pierre Senesse, et al.
Nutrition and Cancer|August 24, 2016
Detailed Dietary Assessment in Patients with Inoperable Tumors: Potential Deficits for Nutrition Care PlansNikoletta Vidra, Meropi D Kontogianni, Evaggelia Schina, et al.
The American Journal of Clinical Nutrition|February 19, 2010
Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysisVickie E Baracos, Tony Reiman, Marina Mourtzakis, et al.
European Journal of Pharmacology|August 4, 2011
Beyond anorexia -cachexia. Nutrition and modulation of cancer patients' metabolism: supplementary, complementary or alternative anti-neoplastic therapy?Alessandro Laviano, Marilia Seelaender, Karla Sanchez-Lara, et al.
Life (Basel, Switzerland)|June 24, 2022
Cancer Cachexia and Antitumor Immunity: Common Mediators and Potential Targets for New TherapiesKonstantinos Rounis, Dimitrios Makrakis, Ioannis Gioulbasanis, et al.
Nutrition and Cancer|January 23, 2023
Objective Measurements of Physical Function to Predict Survival in Patients with Metastatic CancerIoannis Migdanis, Ioannis Gioulbasanis, Athanasios Migdanis, et al.
Journal of Negative Results in Biomedicine|January 7, 2012
Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancerPanagiotis J Vlachostergios, Foteini Karasavvidou, Grigorios Kakkas, et al.
Anticancer Research|November 27, 2008
Gefitinib in combination with gemcitabine and vinorelbine in patients with metastatic breast cancer pre-treated with taxane and anthracycline chemotherapy: a phase I/II trialIoannis Gioulbasanis, Zacharenia Saridaki, Antonia Kalykaki, et al.
Cancer Chemotherapy and Pharmacology|September 11, 2010
Α multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancerNikolaos Xenidis, Nikolaos Vardakis, Ioannis Varthalitis, et al.
Pageof 3